FDA Approves Companion Test to Identify Patients Eligible for New NSCLC Treatment
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
Digital pathology has traditionally been associated with large academic institutions, but recent advancements have made it accessible for mid-sized and community hospital labs.
Despite powerful advances in precision medicine, most doctors remain untrained in these emerging diagnostic tools.
Daxor Corporation has expanded its blood volume analysis technology into three new hospitals, highlighting demand for its lab service.
Proscia is scaling its AI-powered Concentriq pathology platform, driving adoption through a variety of clinical and business benefits.
Diatron has launched the P780, a high-performance, cost-efficient clinical chemistry analyzer designed for medium to large laboratories.
A new diagnostic classification module for AHEAD Medicine's Cyto-Copilot platform enhances AML versus non-neoplastic classification.
MeMed has unveiled MeMed BV Flex, a rapid fingerstick-based test that distinguishes bacterial from viral infections in 15 minutes.
A real-world study at Our Lady of the Lake Regional Medical Center found Cytovale's IntelliSep test significantly reduced sepsis mortality.
Researchers have developed a blood-based proteomics model that accurately predicts disease progression in ADPKD.
Bruker's MALDI Biotyper sirius and sirius one systems have received the ACT Label from My Green Lab, recognizing responsible design.
Natera has received two new FDA Breakthrough Device Designations for its personalized Signatera ctDNA test.
Labcorp and NOWDiagnostics have partnered to distribute free First to Know Syphilis Test kits to public health organizations nationwide.
TOBY, Inc. has completed its participation in the prestigious Mayo Clinic and Arizona State University MedTech Accelerator.